These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7046953)
21. In vitro inhibition of the classical pathway of human complement by polymyxin B. Asghar SS; Boot T; van der Helm HJ Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426 [TBL] [Abstract][Full Text] [Related]
22. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide. Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of macrophage migration by plasma factor(s) from patients with neoplasms and normal individuals. Bice DE; Gruwell D; Salvaggio J J Reticuloendothel Soc; 1976 May; 19(5):281-9. PubMed ID: 775085 [No Abstract] [Full Text] [Related]
24. Studies of assay conditions for macrophage migration from an agarose droplet. Fahlbusch B; Dornberger G Acta Biol Med Ger; 1979; 38(10):1453-60. PubMed ID: 44954 [TBL] [Abstract][Full Text] [Related]
29. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B. Inada K Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561 [TBL] [Abstract][Full Text] [Related]
30. A macrophage surface component related to fibronectin is involved in the response to migration inhibitory factor. Remold HG; Shaw JE; David JR Cell Immunol; 1981 Feb; 58(1):175-87. PubMed ID: 7013990 [No Abstract] [Full Text] [Related]
31. Potentiation of the macrophage response to migration inhibition factor from fetal calf serum by blood group substances with human H activity. Fox RA; MacSween JM; McGuire RL Scand J Immunol; 1976; 5(8):941-7. PubMed ID: 792986 [TBL] [Abstract][Full Text] [Related]
32. Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. Weiser WY; Pozzi LM; David JR J Immunol; 1991 Sep; 147(6):2006-11. PubMed ID: 1909737 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of macrophage migration by a soluble factor from lymphocytes stimulated with PHA or ALS. Lamelin JP; Vassalli P Nature; 1971 Feb; 229(5284):426-8. PubMed ID: 4926999 [No Abstract] [Full Text] [Related]
34. Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes. Piessens WF; Remold HG; David JR J Immunol; 1977 Jun; 118(6):2078-82. PubMed ID: 325137 [TBL] [Abstract][Full Text] [Related]